A detailed history of Divisadero Street Capital Management, LP transactions in Axogen, Inc. stock. As of the latest transaction made, Divisadero Street Capital Management, LP holds 26,272 shares of AXGN stock, worth $389,876. This represents 0.05% of its overall portfolio holdings.

Number of Shares
26,272
Previous 686,994 96.18%
Holding current value
$389,876
Previous $4.97 Million 92.6%
% of portfolio
0.05%
Previous 0.86%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$7.52 - $14.69 $4.97 Million - $9.71 Million
-660,722 Reduced 96.18%
26,272 $368,000
Q2 2024

Aug 12, 2024

BUY
$5.67 - $8.06 $3.33 Million - $4.73 Million
587,024 Added 587.2%
686,994 $4.97 Million
Q1 2024

May 15, 2024

BUY
$6.63 - $10.69 $358,026 - $577,270
54,001 Added 117.47%
99,970 $806,000
Q4 2023

Feb 14, 2024

BUY
$3.61 - $7.76 $165,948 - $356,719
45,969 New
45,969 $313,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $627M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Divisadero Street Capital Management, LP Portfolio

Follow Divisadero Street Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Divisadero Street Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Divisadero Street Capital Management, LP with notifications on news.